A PSA test is a blood test that measures prostate-specific antigen, a protein made mostly by the prostate. For men ages 55 to 69, the U.S. Preventive Services Task Force says the decision to get screened should be made with a doctor, based on your own values and health history. For men 70 and older, the USPSTF recommends against routine PSA screening. There is no single “right answer” for everyone — that is the whole reason this is called a shared decision.
See a Doctor Promptly If You Notice These Symptoms
PSA screening is about catching cancer before symptoms appear. But some urinary or pelvic symptoms should never wait for a routine screening conversation. Contact a doctor promptly if you have:
- Blood in your urine or semen
- Sudden difficulty urinating or an inability to urinate
- New, unexplained pain in your back, hips, or pelvis
- Unexplained weight loss along with urinary changes
These symptoms have many possible causes, and only a clinician can sort out what’s going on.
What the PSA Test Actually Measures
PSA stands for prostate-specific antigen. It’s a substance made mostly by prostate cells, and small amounts normally circulate in the blood. A PSA test measures how much is in a blood sample. Levels can rise because of prostate cancer, but also because of a urinary infection, an enlarged prostate (BPH), recent ejaculation, or even a recent bike ride or prostate exam. This is a core reason PSA testing is imperfect: a high number does not automatically mean cancer, and a normal number does not fully rule it out. According to the National Cancer Institute, there is currently no single standard or routine screening test that reliably confirms prostate cancer on its own — PSA and a digital rectal exam are the two tools doctors use, and an abnormal result on either usually leads to further evaluation, not an automatic diagnosis.
Current USPSTF Screening Guidance by Age
The USPSTF is the independent panel that reviews screening evidence for the U.S. government. Its most recent full recommendation statement on prostate cancer screening was published in 2018 and organizes guidance by age group:
- Under 55: No specific grade. The USPSTF found the evidence inadequate to make a recommendation for this age group.
- 55–69 (Grade C): Screening should be an individual decision. Talk with your doctor about the potential benefits and harms before deciding.
- 70 and older (Grade D): The USPSTF recommends against routine PSA-based screening in this age group.
The USPSTF has noted this topic is under review for a possible update, so it’s worth asking your doctor whether the guidance has changed since your last checkup.
Why This Is Debated: Overdiagnosis and Overtreatment
Screening sounds like it should always help. With prostate cancer, it’s more complicated. Many prostate cancers grow so slowly that they would never cause symptoms or shorten a man’s life. Finding and treating one of these slow-growing cancers is called overdiagnosis, and treating it is called overtreatment.
This matters because prostate cancer treatment carries real risks, including erectile dysfunction and urinary incontinence. The USPSTF describes the benefit of screening as a small potential reduction in the chance of dying from prostate cancer for some men, weighed against a more common risk of false-positive results, unnecessary biopsies, and treatment of cancers that may never have caused harm. That trade-off — a possible small benefit against a real chance of harm from over-treating a slow-growing cancer — is the center of the entire screening debate.
A Decision Path: Talking to Your Doctor About PSA Screening
Instead of guessing what’s right, use this as a starting worksheet for a conversation with your doctor.
- Check your age group. Are you under 55, 55–69, or 70 and older? This changes what current guidelines recommend.
- Review your personal risk factors. Family history of prostate cancer and being a Black man are both associated with higher risk, according to the National Cancer Institute.
- Ask your doctor to explain both possible outcomes. What happens if the PSA test comes back high? What happens if it comes back normal? What would each result lead to next?
- Ask about the harms, not just the benefits. Ask specifically about false positives, biopsy risks, and what overtreatment could mean for you.
- Decide together, not alone. The USPSTF’s own language calls this “an individual decision” for men 55–69 — meaning your preferences count as much as the numbers.
Extra Caution: Higher-Risk Groups
Some men have a higher baseline risk of prostate cancer and may want to raise screening earlier or more directly with their doctor. According to the National Cancer Institute, prostate cancer occurs more often in Black men, and Black men also have higher prostate cancer mortality rates than other groups in the U.S. Having a father or brother with prostate cancer also raises personal risk. If either applies to you, mention it specifically when you talk with your doctor about screening timing — general guidelines are a starting point, not a substitute for that conversation.
What Supplements Can and Cannot Do
Some men look into prostate supplements when they start thinking about prostate health. It’s worth being clear about what these products are for. Ingredients like saw palmetto and beta-sitosterol are studied mainly for urinary symptoms tied to an enlarged prostate (BPH), not for cancer screening or prevention. No supplement replaces a PSA test, a doctor’s evaluation, or a cancer screening decision. If you want to understand how these ingredients are evaluated and what the evidence actually shows, our prostate supplement guide breaks that down separately from the screening topic covered here.
Evidence Limits
Prostate cancer screening research has real limits worth knowing. Large screening trials have produced mixed results on whether PSA screening clearly reduces deaths from prostate cancer, which is part of why the USPSTF assigns a “C” grade (individual decision) rather than a straightforward “yes” for men 55–69. Guidance can also change as new evidence comes in — the USPSTF has flagged this topic as under review. This article reflects the most recent published USPSTF and National Cancer Institute guidance available at the time of writing; ask your doctor whether anything has been updated since.
Frequently Asked Questions
Should I get a PSA test?
That depends on your age, family history, and personal preferences. For men 55–69, the USPSTF says this should be an individual decision made with a doctor. For men 70 and older, routine screening is not recommended. A doctor can help you weigh your specific situation.
What does a high PSA number mean?
A high PSA result does not mean you have cancer. It means further evaluation is usually needed, since PSA can rise due to infection, an enlarged prostate, recent ejaculation, or other non-cancer causes. Only a doctor can interpret your result in context.
Why don’t doctors recommend PSA screening for everyone?
Because many prostate cancers grow so slowly they would never cause harm, screening can lead to finding and treating cancers that didn’t need treatment. That overtreatment carries real risks like incontinence and erectile dysfunction, which is why guidelines call for weighing benefits and harms individually rather than screening every man automatically.
Can supplements lower my prostate cancer risk or replace screening?
No. Supplements are not a substitute for PSA testing or a doctor’s evaluation, and none are established to prevent prostate cancer. Ingredients like saw palmetto and beta-sitosterol are studied for urinary symptoms, not for cancer screening or risk reduction.
This article is for general education only and is not medical advice, a diagnosis, or a treatment recommendation. Screening decisions should be made with a qualified doctor who knows your health history. If you have urgent symptoms like blood in your urine, an inability to urinate, or unexplained pain, contact a doctor promptly.
Guideline/shared-decision page. For a different reader task, see what PSA and DRE results can and cannot tell you.